Today's Top Patent Stories

17 new stories

Jun 25th 2026

1. Bosch patents Pellet 3D printer without refill pauses - 3Druck.com

Domain: 3druck.com

The documents are patents, not product announcements. Whether Bosch intends to commercialize such a machine is not indicated in the filings. Large ...

2. Case: Patents/Procedure (Fed. Cir.) - Bloomberg Law News

Domain: news.bloomberglaw.com

Case: Patents/Procedure (Fed. Cir.) June 25, 2026, 6:15 AM PDT. The Federal Circuit affirmed the decision of a federal district court in Virginia ...

3. Case: Patents/Summary Judgment (4th Cir.) - Bloomberg Law News

Domain: news.bloomberglaw.com

Case: Patents/Summary Judgment (4th Cir.) June 24, 2026, 10:14 AM PDT. The Fourth Circuit affirmed the decision of a federal district court in ...

4. Valence AI Raises $5 Million And Secures U.S. Patents For Real-Time Emotional Detection ...

Domain: pulse2.com

Valence AI announced $5 million in total funding and the issuance of two U.S. patents covering the company's proprietary audio signal processing ...

5. Samsung Faces Legal Challenge Over LED Patents in the US - SammyGuru

Domain: sammyguru.com | Companies: Samsung

... patents. These patents are centered around opto-semiconductor technologies that improve the performance of LED and microLED devices. The ...

6. Monthly statistics: Patents, trade marks and designs: May 2026 - GOV.UK

Domain: gov.uk

These statistics include monthly data for patents, trade marks and designs.

7. Patent Enablement Considerations for Pharma and Biotech Inventions in Vietnam

Domain: lexology.com

” In pharmaceutical and biotechnology patents, this requirement is more complicated and subject to more rigorous assessment. The Patent ...

8. Amgen v Sanofi: EPO appeal withdrawal confirms European alignment - Lexology

Domain: lexology.com | Companies: Amgen

Further to our recent article discussing the global dispute between Sanofi/Regeneron and Amgen over the validity of patents covering therapeutic…

9. Substance Over Form: How The Delhi And Madras High Courts Are Rewriting The Rules For ...

Domain: livelaw.in

... Patents Act, 1970. If the Controller of Patents refuses the application, the applicant may challenge that refusal before the High Court. This ...

10. Red and green flags: how IP firms pick funding partners | Managing Intellectual Property

Domain: managingip.com

Choosing the right one will hinge on how clear a firm is about its long-term goals. Topics. AnalysisTrademarksPatentsEuropeInternationalNews · sukanya ...

11. Full Federal Circuit Won't Consider DePuy's Challenge To Patent Witness Ruling - Mealey's

Domain: mealeys.com

... physician who claimed that the DePuy entities induced surgeons to infringe certain claims of his patents.

12. New Zealand | Patents Amendments Act 2026: The Great Kiwi Divisional Dash

Domain: mondaq.com

New Zealand's Parliament has passed the Patents Amendments Bill 2025, addressing a long-standing inconsistency in patent law regarding divisional ...

13. Dickinson Wright recognized in Legal 500 United States 2026 Edition

Domain: nnbw.com

Dispute Resolution – General Commercial Disputes – Mid-Market ($0-250m); Industry Focus – Cannabis; Intellectual Property – Patents: Licensing ...

14. Hero Patents New Budget Commuter Bike – Likely For Export Markets - RushLane

Domain: rushlane.com

Combined with models like Passion and Glamour, entry-level motorcycles make up nearly 90% of Hero's overall volumes. Hero Patents New Bike. The newly ...

15. A black market for 'fake patents' is a new poison in Indian research - The Hindu

Domain: thehindu.com

A black market for fake patents in India threatens research integrity, as companies exploit academics for academic reputation gains.

16. Congress deserves evidence on patents, not more slogans - The News-Enterprise

Domain: thenewsenterprise.com

The evidence tells a different story: Generic competition routinely arrives years before all patents associated with a medicine expire, and more than ...

17. ANTITRUST NEWS—4th Cir.: FTC files amicus brief challenging monopolization ... - VitalLaw.com

Domain: vitallaw.com

The J&J acquisition of Momenta included four manufacturing patents for ustekinumab biosimilars (Momenta manufacturing patents). CareFirst alleged ...